Special Edition: The COVID-19 PandemicApril 27, 2020 | Oncology Allergy & Immunology Presenting Characteristics, Comorbidities, and Outcomes of Patients Hospitalized With COVID-19 A JAMA “Original Investigation” seeks to discover the characteristics, clinical presentation, and outcomes of 5,700 patients hospitalized with COVID-19 in the United States, specifically in the New York City area. Read full article Allergy & Immunology Timely Antiviral Therapy May Slow COVID-19 Progression; More Study Needed The Journal of Internal Medicine stresses that, although the timing of antiviral therapy may significantly slow COVID-19 progression, the study was underpowered to evaluate the therapeutic effect of the drugs and they should continue to be used only in studies, not empirical use. Read full article Allergy & Immunology Ibrutinib May Improve Pulmonary Outcomes in Certain COVID-19 Cases Although the findings reported in Blood should be considered as hypothesis-generating and preliminary in nature, a small clinical trial suggested ibrutinib may protect against lung injury and improve pulmonary function in hypoxic patients with COVID-19. Read full article
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS